ModelMatcher: A scientist-centric online platform to facilitate collaborations between stakeholders of rare and undiagnosed disease research.

Matchmaker Exchange (MME) Rare Diseases Models and Mechanisms (RDMM) Network Undiagnosed Diseases Network (UDN) collaboration functional studies matchmaking model organisms rare diseases undiagnosed diseases variants of unknown significance (VUS)

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
06 2022
Historique:
revised: 12 02 2022
received: 30 09 2021
accepted: 23 02 2022
pubmed: 1 3 2022
medline: 25 5 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

Next-generation sequencing is a prevalent diagnostic tool for undiagnosed diseases and has played a significant role in rare disease gene discovery. Although this technology resolves some cases, others are given a list of possibly damaging genetic variants necessitating functional studies. Productive collaborations between scientists, clinicians, and patients (affected individuals) can help resolve such medical mysteries and provide insights into in vivo function of human genes. Furthermore, facilitating interactions between scientists and research funders, including nonprofit organizations or commercial entities, can dramatically reduce the time to translate discoveries from bench to bedside. Several systems designed to connect clinicians and researchers with a shared gene of interest have been successful. However, these platforms exclude some stakeholders based on their role or geography. Here we describe ModelMatcher, a global online matchmaking tool designed to facilitate cross-disciplinary collaborations, especially between scientists and other stakeholders of rare and undiagnosed disease research. ModelMatcher is integrated into the Rare Diseases Models and Mechanisms Network and Matchmaker Exchange, allowing users to identify potential collaborators in other registries. This living database decreases the time from when a scientist or clinician is making discoveries regarding their genes of interest, to when they identify collaborators and sponsors to facilitate translational and therapeutic research.

Identifiants

pubmed: 35224820
doi: 10.1002/humu.24364
pmc: PMC9133126
mid: NIHMS1785744
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

743-759

Subventions

Organisme : NIH HHS
ID : U54NS093793
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : CIHR
ID : RCN-137793
Pays : Canada
Organisme : NINDS NIH HHS
ID : U54 NS093793
Pays : United States
Organisme : CIHR
ID : RCN-160422
Pays : Canada

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Nucleic Acids Res. 2020 Jul 2;48(W1):W538-W545
pubmed: 32374845
Genet Med. 2016 Aug;18(8):788-95
pubmed: 26656649
Mol Genet Metab. 2016 Apr;117(4):393-400
pubmed: 26846157
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Cell. 2011 Sep 30;147(1):32-43
pubmed: 21962505
Mol Genet Metab. 2020 Apr;129(4):243-254
pubmed: 32033911
Nat Commun. 2010 Nov 30;1:131
pubmed: 21119644
J Vis Exp. 2019 Aug 20;(150):
pubmed: 31498321
Nat Commun. 2020 Apr 29;11(1):2073
pubmed: 32350270
Nat Genet. 2019 Mar;51(3):404-413
pubmed: 30617256
Sci Adv. 2019 May 22;5(5):eaav6528
pubmed: 31131321
Am J Hum Genet. 2020 Feb 6;106(2):143-152
pubmed: 32032513
Am J Hum Genet. 2014 Jun 5;94(6):809-17
pubmed: 24906018
Hum Mutat. 2015 Oct;36(10):985-8
pubmed: 26220576
Nat Commun. 2018 Jul 27;9(1):2941
pubmed: 30054458
Genome Biol. 2017 Nov 28;18(1):225
pubmed: 29179779
J Genet Couns. 2018 Aug;27(4):935-946
pubmed: 29297108
Genetics. 2017 Sep;207(1):9-27
pubmed: 28874452
Science. 2018 Nov 30;362(6418):1055-1060
pubmed: 30385465
BMC Bioinformatics. 2011 Aug 31;12:357
pubmed: 21880147
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
Genet Med. 2021 Oct;23(10):1889-1900
pubmed: 34113007
Am J Hum Genet. 2020 Dec 3;107(6):1096-1112
pubmed: 33232675
Genome Biol. 2012 Jan 31;13(1):R5
pubmed: 22293552
Hum Mutat. 2015 Oct;36(10):931-40
pubmed: 26251998
Orphanet J Rare Dis. 2021 May 7;16(1):206
pubmed: 33962631
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Nucleic Acids Res. 2021 Jan 8;49(D1):D939-D946
pubmed: 33152070
Nucleic Acids Res. 2020 Jan 8;48(D1):D650-D658
pubmed: 31552413
Eur J Hum Genet. 2020 Feb;28(2):165-173
pubmed: 31527858
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12603-12607
pubmed: 30530676
Hum Mutat. 2015 Apr;36(4):425-31
pubmed: 25684268

Auteurs

J Michael Harnish (JM)

Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.

Lucian Li (L)

Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Department of Pediatrics, Division of Neurology and Developmental Neuroscience, BCM, Houston, Texas, USA.

Sanja Rogic (S)

Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Guillaume Poirier-Morency (G)

Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Seon-Young Kim (SY)

Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Department of Pediatrics, Division of Neurology and Developmental Neuroscience, BCM, Houston, Texas, USA.

Kym M Boycott (KM)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Michael F Wangler (MF)

Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Development, Disease Models and Therapeutics Graduate Program, BCM, Houston, Texas, USA.

Hugo J Bellen (HJ)

Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Development, Disease Models and Therapeutics Graduate Program, BCM, Houston, Texas, USA.
Department of Neuroscience, BCM, Houston, Texas, USA.

Philip Hieter (P)

Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.

Paul Pavlidis (P)

Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Zhandong Liu (Z)

Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Department of Pediatrics, Division of Neurology and Developmental Neuroscience, BCM, Houston, Texas, USA.
Quantitative and Computational Biosciences Graduate Program, BCM, Houston, Texas, USA.

Shinya Yamamoto (S)

Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, Texas, USA.
Development, Disease Models and Therapeutics Graduate Program, BCM, Houston, Texas, USA.
Department of Neuroscience, BCM, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH